Children with attention deficit hyperactivity disorder (ADHD) do not have a behavioural disorder, nor are they lazy, or lacking in manners and boundaries. Their brains mature in a different way, with ...

Cingulate Inc. (NASDAQ:CING), a micro-cap pharmaceutical company with a market value of $16.4 million specializing in the development of central nervous system (CNS) therapeutics, has announced ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Cingulate Inc ...

Furthermore, oxytocin increased local efficiency, clustering coefficients, and small-world propensity in specific brain regions including the cerebellum, left thalamus, posterior cingulate cortex, ...

Researchers honed in on a node in the brain, the subcallosal cingulate gyrus (SCG), that has been shown in previous research to be implicated in depression. The team measured mood and depression ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

They honed in on a node in the brain, the subcallosal cingulate gyrus (SCG), that has been shown in previous research to be implicated in depression. They measured mood and depression scores in ...

Cingulate Inc. secures $5 million in financing to support clinical and operational activities, targeting NDA filing for CTx-1301 by mid-2025. Cingulate Inc. has secured $5 million in net proceeds ...